 |
市场调查报告书
商品编码
1880370
全球基因组学市场（至 2030 年）按产品（试剂、试剂盒、仪器）、服务（基因组分析、生物资讯学）、技术（定序、PCR、ISH、流式细胞技术）、研究类型（表观基因）和应用（药物发现、诊断、农业）划分Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030 |
||||||
价格
全球基因组学市场预计将从 2025 年的 470.7 亿美元成长到 2030 年的 850.9 亿美元，预测期（2025-2030 年）的复合年增长率为 12.6%。
基因组学市场正经历强劲成长，这得益于政府资金的增加、病毒和遗传疾病的日益普及以及次世代定序(NGS) 技术的不断进步。
| 调查范围 | |
|---|---|
| 调查期 | 2024-2030 |
| 基准年 | 2024 |
| 预测期 | 2025-2030 |
| 单元 | 金额（美元） |
| 部分 | 提供类别、产品、服务、技术、应用、研究类型 |
| 目标区域 | 北美、欧洲、亚太地区、拉丁美洲、中东和非洲 |
除了在遗传疾病鑑定和药物研发方面的传统应用外，基因组学在农业、兽医学和法医学也日益受到关注。在法医学领域，次世代定序（NGS）技术的引入彻底革新了DNA分析，以全面的基因组重建取代了传统的DNA指纹图谱方法，从而实现了更精确的鑑定。 NGS也有助于现场分析，能够从微量或劣化的DNA样本中提取详细的遗传讯息，提高了法医学调查的准确性和范围。
“按产品类型划分，试剂、试剂盒和耗材细分市场预计在预测期内将实现最高的复合年增长率。”
依产品类型划分，试剂、试剂盒和耗材占最大份额。试剂和试剂盒几乎是所有基因组学工作流程的必需品，包括DNA和RNA的萃取、扩增、定序和分析。它们对于研究和临床应用都至关重要。诊断、个人化医疗和药物研发领域基因组学实验数量的不断增长，推动了对这些产品的需求。每个工作流程都需要稳定的高品质试剂和试剂盒供应，以确保产生准确可靠的基因组数据。
此外，次世代定序(NGS) 和聚合酵素链锁反应(PCR) 等先进技术的快速普及，进一步提升了对特定应用试剂和耗材的需求。基因组学领域（包括医疗保健、研究和生物技术）的持续成长，推动了耗材收入的增加，并巩固了主导地位。
「按最终用户划分，到2024年，医院、诊断实验室和诊所将占据最大份额。”
这个终端用户群体的大部分增长得益于患者透过公民科学倡议更多地参与基因组研究，这些计划旨在实现数据收集的民主化，并加速罕见疾病和个性化医疗领域的发现。製药和生物技术公司是第二大终端用户群。
“美国主导北美市场”
美国是全球最大的生物製药市场，也是生物製药研发和投资的领导者。凭藉先进的研究生态系统、雄厚的资金支持以及Illumina、Thermo Fisher Scientific、Agilent Technologies和Danaher等行业领导者的存在，未来几年对基因组产品和服务的需求预计将持续增长。美国受益于政府和私人机构对精准医疗和人群基因组学计画的大量投资，其中包括美国国立卫生研究院（NIH）和「我们所有人」（All of Us）倡议。 NGS和生物资讯学平台在临床和研究领域的高普及率进一步巩固了美国的市场主导。此外，完善的法律规范、强大的医疗保健基础设施以及积极的公私合营也促进了美国基因组技术的持续创新和商业化。
本报告调查了全球基因组学产品和服务市场，并提供了市场概况、影响市场成长的各种因素分析、技术和专利趋势、法律制度、案例研究、市场规模趋势和预测、按各个细分市场、地区/主要国家进行的详细分析、竞争格局以及主要企业的概况。
目录
第一章 引言
第二章调查方法
第三章执行摘要
第四章重要考察
第五章 市场概览
- 市场动态
- 司机
- 抑制因素
- 机会
- 任务
- 未满足的需求和閒置频段
- 与相关市场和不同产业相关的跨领域机会
- 一级/二级/三级公司的策略性倡议
第六章 产业趋势
- 波特五力分析
- 宏观经济展望
- 价值链分析
- 生态系分析
- 定价分析
- 贸易分析
- 2026年重大会议和活动
- 影响您业务的趋势/颠覆性因素
- 投资和资金筹措方案
- 案例研究分析
- 2025年美国关税的影响
第七章：技术进步、人工智慧的影响、专利与创新
- 技术分析
- 关键新兴技术
- 互补技术
- 邻近技术
- 技术/产品蓝图
- 专利分析
- 未来应用
- 人工智慧/生成式人工智慧对基因组学市场的影响
第八章永续性和监管环境
- 地方法规和合规性
- 对永续性的承诺
- 永续性影响和监管政策倡议
- 认证、标籤和环境标准
第九章：顾客状况与购买行为
- 决策流程
- 买方相关人员和采购评估标准
- 招募障碍和内部挑战
- 来自各个终端使用者产业的未满足需求
- 市场盈利
第十章 基因组学市场：依产品细分
- 产品
- 服务
第十一章 基因组学产品市场（按类型划分）
- 试剂、试剂盒及耗材
- 装置
- 生物资讯学工具
12. 按技术分類的基因组学产品市场
- 定序
- PCR
- 基因编辑
- 流式细胞技术
- 微阵列
- 原位杂交
- 其他的
13. 依最终用户分類的基因组学产品市场
- 医院、诊断实验室和诊所
- 学术研究机构
- 製药和生物技术公司
- CRO
- 其他的
第十四章 基因组学服务市场（按类型划分）
- 基因组分析与定序服务
- 样品和样品製备服务
- 生物资讯服务
第十五章 依最终用户分類的基因组学服务市场
- 医院、诊断实验室和诊所
- 学术研究机构
- 製药和生物技术公司
- 其他的
第十六章 按应用分類的基因组学市场
- 药物发现与开发
- 诊断
- 癌症诊断
- 感染疾病
- 生殖健康
- 其他的
- 农业和动物研究
- 其他的
第十七章：依研究类型分類的基因组学市场
- 功能基因体学
- 生物标记发现
- 通路分析
- 表观基因
- 其他的
第十八章：基因组学市场区域概览
- 北美洲
- 宏观经济展望
- 美国
- 加拿大
- 欧洲
- 宏观经济展望
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 其他的
- 亚太地区
- 宏观经济展望
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 其他的
- 拉丁美洲
- 宏观经济展望
- 巴西
- 墨西哥
- 其他的
- 中东
- 宏观经济展望
- 海湾合作委员会国家
- 其他的
- 非洲
- 宏观经济展望
第十九章 竞争情势
- 主要参与企业的策略/优势
- 收入分析
- 市占率分析
- 品牌/产品对比
- 公司评估矩阵：主要企业
- 公司估值矩阵：Start-Ups/中小企业
- 估值和财务指标
- 竞争场景
第二十章 公司简介
- 主要企业
- THERMO FISHER SCIENTIFIC INC.
- ILLUMINA, INC.
- DANAHER CORPORATION
- F. HOFFMANN-LA ROCHE LTD.
- AGILENT TECHNOLOGIES, INC.
- QIAGEN
- REVVITY
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- IQVIA INC.
- CHARLES RIVER LABORATORIES
- BIO-RAD LABORATORIES, INC.
- EUROFINS SCIENTIFIC
- PACBIO
- OXFORD NANOPORE TECHNOLOGIES PLC.
- TAKARA BIO INC.
- BGI GROUP
- EPPENDORF SE
- MERCK KGAA
- BD
- ABBOTT
- 10X GENOMICS
- NEW ENGLAND BIOLABS
- PROMEGA CORPORATION
- 其他公司
- CREATIVE BIOGENE
- NOVOGENE CO., LTD.
- HELIX, INC.
- PHALANX BIOTECH GROUP
- POLARIS GENOMICS
第21章附录
Product Code: BT 2209
The global genomics market is projected to reach USD 85.09 billion by 2030 from USD 47.07 billion in 2025, exhibiting a CAGR of 12.6% from 2025 to 2030. The genomics market is experiencing strong growth, driven by increasing government funding, the rising prevalence of viral and hereditary diseases, and ongoing advancements in next-generation sequencing (NGS) technologies.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2024-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD billion) |
| Segments | Offering, Products, Services, Technology, Applications and Study type |
| Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
Beyond traditional applications in genetic disorder identification and drug discovery, genomics is gaining traction in agriculture, veterinary science, and forensics. In forensics, the adoption of NGS has revolutionized DNA analysis. Traditional DNA fingerprinting methods are being replaced by comprehensive genomic reconstruction, enabling more precise identification. NGS also facilitates on-site analysis, allowing the extraction of detailed genetic information from trace or degraded DNA samples, thereby enhancing the accuracy and scope of forensic investigations.
"The reagents, kits, and consumables segment is projected to record the highest CAGR during the forecast period."
Based on product type, the genomics market is segmented into reagents, kits, and consumables; instruments; and bioinformatics tools. The reagents, kits, and consumables segment accounted for the largest share of the product market. Reagents and kits are essential for nearly all genomic workflows, including DNA and RNA extraction, amplification, sequencing, and analysis. They are vital for both research and clinical applications. The demand for these products is driven by the increasing number of genomic experiments conducted in diagnostics, personalized medicine, and drug development. Each workflow requires a consistent supply of high-quality reagents and kits to ensure the accurate and reliable generation of genomic data.
Moreover, the rapid adoption of advanced technologies such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) further increases the need for application-specific reagents and consumables. The ongoing growth in genomics sectors, such as healthcare, research, and biotechnology, enhances the revenue generated from consumables, solidifying its leading market position.
"The hospitals, diagnostic laboratories, and clinics segment accounted for the largest share in 2024."
In 2024, the hospitals, diagnostic laboratories, and clinics segment accounted for the largest share of the global genomic products market. The large share of this end-user segment can be attributed to increased patient engagement in genomic research, driven by citizen science initiatives. These efforts aim to democratize data collection and accelerate discoveries in rare diseases and personalized medicine. Additionally, pharmaceutical & biotechnology companies hold the second-largest share in this segment.
"The US dominated the North American genomics market in 2024."
The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for genomics products & services is expected to grow over the coming years, driven by its advanced research ecosystem, strong funding support, and presence of major industry leaders such as Illumina, Thermo Fisher Scientific, Agilent Technologies, and Danaher. The country benefits from substantial government and private investments in precision medicine and population genomics programs, including NIH and All of Us initiatives. High adoption of next-generation sequencing (NGS) and bioinformatics platforms across clinical and research settings further supports market leadership. Additionally, a well-established regulatory framework, robust healthcare infrastructure, and active public-private collaborations foster continuous innovation and commercialization of genomic technologies in the US.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side (70%) and Demand Side (30%)
- By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
- By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%)
Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity (US), Laboratory Corporation of America Holdings (US), and IQVIA Inc. (US) are some of the key players operating in the genomics market.
Research Coverage:
This research report categorizes the genomics market by offering {products [type (reagents, kits, and consumables; instruments; and bioinformatics tools), technology (sequencing, PCR, gene editing, flow cytometry, microarrays, in situ hybridization, and other technologies), and end user (hospitals, diagnostic laboratories, and clinics; academic & research institutes; pharmaceutical & biotechnology companies; CROs; and other end users)] and services [type (genomics profiling and sequencing services, sample preparation and library preparation services, and bioinformatics services) and end user (hospitals, diagnostic laboratories, and clinics; academic & research institutes; pharmaceutical & biotechnology companies; and other end users)]}, application (drug discovery & development, diagnostics, agriculture and animal research, and other applications), study type (functional genomics, biomarker discovery, pathway analysis, epigenomics, and other study types), and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa). The report's scope encompasses detailed information regarding the key factors, including drivers, restraints, challenges, and opportunities, that influence market growth. A thorough analysis of key industry players has provided insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, and acquisitions are recent developments in the genomics market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall genomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (increasing government funding for genomics projects, increasing prevalence of viral and inherited disorders, advancements in NGS platforms, and growing applications of genomics), restraints (high investment costs), opportunities (increasing use of genomics in precision medicine and technological advancements in genomics), and challenges (handling of large volume of data sets and their analysis and clinical utility of genomics) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products/services of the genomics market.
- Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions.
- Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the genomics market.
- Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity (US), Laboratory Corporation of America Holdings (US), and IQVIA Inc. (US), among others in the market.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.3.5 UNITS CONSIDERED
- 1.4 STAKEHOLDERS
- 1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key objectives of secondary research
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Breakdown of primaries
- 2.1.2.2 Key objectives of primary research
- 2.1.1 SECONDARY DATA
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 GLOBAL GENOMICS MARKET ESTIMATION, 2024
- 2.2.1.1 Company revenue analysis (bottom-up approach)
- 2.2.1.2 MNM repository analysis
- 2.2.1.3 Primary research
- 2.2.2 SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)
- 2.2.1 GLOBAL GENOMICS MARKET ESTIMATION, 2024
- 2.3 MARKET GROWTH RATE PROJECTIONS
- 2.4 DATA TRIANGULATION
- 2.5 STUDY ASSUMPTIONS
- 2.6 RESEARCH LIMITATIONS
- 2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
- 3.1 KEY INSIGHTS & MARKET HIGHLIGHTS
- 3.2 KEY MARKET PARTICIPANTS: INSIGHTS AND STRATEGIC DEVELOPMENTS
- 3.3 DISRUPTIVE TRENDS SHAPING GENOMICS MARKET
- 3.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
4 PREMIUM INSIGHTS
- 4.1 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
- 4.2 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION AND COUNTRY, 2024
- 4.3 GENOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Increasing government funding for genomics projects
- 5.2.1.2 Increasing prevalence of viral and inherited disorders
- 5.2.1.3 Advancements in NGS platforms
- 5.2.1.4 Growing applications of genomics
- 5.2.2 RESTRAINTS
- 5.2.2.1 High investment costs
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Increasing use of genomics in precision medicine
- 5.2.3.2 Technological advancements in genomics
- 5.2.4 CHALLENGES
- 5.2.4.1 Handling large volumes of data sets and their analysis
- 5.2.4.2 Clinical utility of genomics
- 5.2.1 DRIVERS
- 5.3 UNMET NEEDS AND WHITE SPACES
- 5.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
- 5.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
6 INDUSTRY TRENDS
- 6.1 PORTER'S FIVE FORCES ANALYSIS
- 6.1.1 INTENSITY OF COMPETITIVE RIVALRY
- 6.1.2 BARGAINING POWER OF SUPPLIERS
- 6.1.3 BARGAINING POWER OF BUYERS
- 6.1.4 THREAT OF SUBSTITUTES
- 6.1.5 THREAT OF NEW ENTRANTS
- 6.2 MACROECONOMIC OUTLOOK
- 6.2.1 INTRODUCTION
- 6.2.2 GDP TRENDS AND FORECAST
- 6.2.3 TRENDS IN GLOBAL GENOMICS INDUSTRY
- 6.3 VALUE CHAIN ANALYSIS
- 6.4 ECOSYSTEM ANALYSIS
- 6.4.1 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS
- 6.5 PRICING ANALYSIS
- 6.5.1 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022-2024
- 6.5.2 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022-2024
- 6.5.3 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024
- 6.5.4 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022-2024
- 6.6 TRADE ANALYSIS
- 6.6.1 IMPORT SCENARIO (HS CODE 3822 & 902789)
- 6.6.2 EXPORT SCENARIO (HS CODE 3822 & 902789)
- 6.7 KEY CONFERENCES AND EVENTS, 2026
- 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 6.9 INVESTMENT AND FUNDING SCENARIO
- 6.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
- 6.10 CASE STUDY ANALYSIS
- 6.11 IMPACT OF 2025 US TARIFFS-GENOMICS MARKET
- 6.11.1 INTRODUCTION
- 6.11.2 KEY TARIFF RATES
- 6.11.3 PRICE IMPACT ANALYSIS
- 6.11.4 IMPACT ON COUNTRIES/REGIONS
- 6.11.4.1 US
- 6.11.4.2 Europe
- 6.11.4.3 Asia Pacific
- 6.11.5 IMPACT ON END-USE INDUSTRIES
- 6.11.5.1 Pharmaceutical & biotechnology companies
- 6.11.5.2 CROs and academic & research institutes
- 6.11.5.3 Hospitals, diagnostic laboratories, and clinics
7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS
- 7.1 TECHNOLOGICAL ANALYSIS
- 7.1.1 KEY EMERGING TECHNOLOGIES
- 7.1.1.1 Sequencing by synthesis
- 7.1.1.2 Single-molecule real-time sequencing
- 7.1.1.3 Nanopore sequencing
- 7.1.1.4 qPCR
- 7.1.1.5 dPCR
- 7.1.1.6 Microarray technology
- 7.1.2 COMPLEMENTARY TECHNOLOGIES
- 7.1.2.1 Cytogenetics
- 7.1.2.2 Synthetic biology
- 7.1.2.3 Multiomics
- 7.1.2.4 Single-cell analysis
- 7.1.3 ADJACENT TECHNOLOGIES
- 7.1.3.1 Bioinformatics and computational biology
- 7.1.3.2 Artificial intelligence and machine learning
- 7.1.1 KEY EMERGING TECHNOLOGIES
- 7.2 TECHNOLOGY/PRODUCT ROADMAP
- 7.3 PATENT ANALYSIS
- 7.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR GENOMICS PATENTS, 2014-2024
- 7.4 FUTURE APPLICATIONS
- 7.5 IMPACT OF AI/GEN AI ON GENOMICS MARKET
- 7.5.1 BEST PRACTICES IN GENOMICS WORKFLOW
- 7.5.2 CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET
- 7.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 7.5.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN GENOMICS MARKET
8 SUSTAINABILITY AND REGULATORY LANDSCAPE
- 8.1 REGIONAL REGULATIONS AND COMPLIANCE
- 8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 8.1.2 INDUSTRY STANDARDS
- 8.2 SUSTAINABILITY INITIATIVES
- 8.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
- 8.4 CERTIFICATIONS, LABELING, ECO-STANDARDS
9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 9.1 DECISION-MAKING PROCESS
- 9.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 9.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 9.2.2 KEY BUYING CRITERIA, BY END USER
- 9.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 9.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- 9.5 MARKET PROFITABILITY
10 GENOMICS MARKET, BY OFFERING
- 10.1 INTRODUCTION
- 10.2 PRODUCTS
- 10.2.1 ACCELERATION OF HIGH-THROUGHPUT GENOMICS DRIVEN BY PLATFORM INNOVATION AND AUTOMATION IS BOOSTING GROWTH
- 10.3 SERVICES
- 10.3.1 RAPID EXPANSION OF GENOMIC SERVICES FUELED BY CLINICAL ADOPTION AND DATA-DRIVEN DECISION SUPPORT
11 GENOMICS PRODUCTS MARKET, BY TYPE
- 11.1 INTRODUCTION
- 11.2 REAGENTS, KITS, AND CONSUMABLES
- 11.2.1 LARGE NUMBER OF PLAYERS OPERATING IN CONSUMABLES SPACE PROPEL DEMAND FOR REAGENTS, KITS, AND CONSUMABLES
- 11.3 INSTRUMENTS
- 11.3.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
- 11.4 BIOINFORMATICS TOOLS
- 11.4.1 ACCELERATING GENOMIC INSIGHTS THROUGH SCALABLE, AI-ENABLED BIOINFORMATICS PLATFORMS DRIVE MARKET GROWTH
12 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY
- 12.1 INTRODUCTION
- 12.2 SEQUENCING
- 12.2.1 DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH
- 12.3 PCR
- 12.3.1 RISING DEMAND FOR BIOMARKER DISCOVERY TO PROPEL MARKET GROWTH
- 12.4 GENE EDITING
- 12.4.1 RISING DEMAND FOR NEWER THERAPEUTIC APPROACHES DRIVING GROWTH
- 12.5 FLOW CYTOMETRY
- 12.5.1 RISING DEMAND FOR FLOW CYTOMETRY IN AGRIGENOMICS TO DRIVE MARKET GROWTH
- 12.6 MICROARRAYS
- 12.6.1 RISING ADOPTION OF HIGH-THROUGHPUT TECHNOLOGIES LIMITING MARKET GROWTH
- 12.7 IN SITU HYBRIDIZATION
- 12.7.1 INCREASING DEMAND FOR PRECISE GENE EXPRESSION ANALYSIS DRIVING GROWTH
- 12.8 OTHER TECHNOLOGIES
13 GENOMICS PRODUCTS MARKET, BY END USER
- 13.1 INTRODUCTION
- 13.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
- 13.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH
- 13.3 ACADEMIC & RESEARCH INSTITUTES
- 13.3.1 RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
- 13.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 13.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS PROPELS MARKET
- 13.5 CROS
- 13.5.1 RISING COLLABORATION BETWEEN PHARMA COMPANIES AND CROS DRIVING MARKET GROWTH
- 13.6 OTHER END USERS
14 GENOMICS SERVICES MARKET, BY TYPE
- 14.1 INTRODUCTION
- 14.2 GENOMIC PROFILING & SEQUENCING SERVICES
- 14.2.1 INCREASED ADOPTION OF SEQUENCING TECHNOLOGIES IN CLINICAL ADOPTION TO SUPPORT MARKET GROWTH
- 14.3 SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES
- 14.3.1 INCREASED DEMAND FOR ONCOLOGY AND RARE DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH
- 14.4 BIOINFORMATICS SERVICES
- 14.4.1 RISING DEMAND FOR ADVANCED PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
15 GENOMICS SERVICES MARKET, BY END USER
- 15.1 INTRODUCTION
- 15.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
- 15.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH
- 15.3 ACADEMIC & RESEARCH INSTITUTES
- 15.3.1 RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
- 15.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 15.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO DRIVE GROWTH
- 15.5 OTHER END USERS
16 GENOMICS MARKET, BY APPLICATION
- 16.1 INTRODUCTION
- 16.2 DRUG DISCOVERY & DEVELOPMENT
- 16.2.1 DRUG DISCOVERY & DEVELOPMENT TO BE LARGEST APPLICATION IN GENOMICS MARKET
- 16.3 DIAGNOSTICS
- 16.3.1 CANCER DIAGNOSTICS
- 16.3.1.1 Rising demand for targeted therapies to drive market growth
- 16.3.2 INFECTIOUS DISEASES
- 16.3.2.1 Rising demand for comprehensive genomic data in clinical genomics to drive market growth
- 16.3.3 REPRODUCTIVE HEALTH
- 16.3.3.1 Rising focus on genetic diseases to drive market growth
- 16.3.4 OTHER DIAGNOSTIC APPLICATIONS
- 16.3.1 CANCER DIAGNOSTICS
- 16.4 AGRICULTURE & ANIMAL RESEARCH
- 16.4.1 GENOMICS TO HELP IMPROVE CROP PRODUCTIVITY
- 16.5 OTHER APPLICATIONS
17 GENOMICS MARKET, BY STUDY TYPE
- 17.1 INTRODUCTION
- 17.2 FUNCTIONAL GENOMICS
- 17.2.1 INCREASED FOCUS ON FUNCTIONAL GENOME STUDIES TO DRIVE MARKET GROWTH
- 17.3 BIOMARKER DISCOVERY
- 17.3.1 RISING DEMAND FOR PRECISION MEDICINE TO SUPPORT MARKET GROWTH
- 17.4 PATHWAY ANALYSIS
- 17.4.1 RISING PREVALENCE OF COMPLEX DISEASES TO AUGMENT MARKET GROWTH
- 17.5 EPIGENOMICS
- 17.5.1 RISING INVESTMENTS FOR EPIGENETICS RESEARCH TO BOOST MARKET GROWTH
- 17.6 OTHER STUDY TYPES
18 GENOMICS MARKET, BY REGION
- 18.1 INTRODUCTION
- 18.2 NORTH AMERICA
- 18.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
- 18.2.2 US
- 18.2.2.1 US expected to dominate market in North America
- 18.2.3 CANADA
- 18.2.3.1 Increasing government initiatives in genomics research to boost market growth
- 18.3 EUROPE
- 18.3.1 EUROPE: MACROECONOMIC OUTLOOK
- 18.3.2 GERMANY
- 18.3.2.1 Germany to dominate European genomics market
- 18.3.3 UK
- 18.3.3.1 Strategic initiatives and funding for genomics research to support market growth
- 18.3.4 FRANCE
- 18.3.4.1 Increasing government investment in genomics research to drive growth
- 18.3.5 ITALY
- 18.3.5.1 Favorable funding scenario to drive adoption of advanced sequencing technology
- 18.3.6 SPAIN
- 18.3.6.1 Growing focus on advancements in personalized medicine to support market growth
- 18.3.7 REST OF EUROPE
- 18.4 ASIA PACIFIC
- 18.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
- 18.4.2 CHINA
- 18.4.2.1 China to dominate Asia Pacific market during forecast period
- 18.4.3 JAPAN
- 18.4.3.1 Rising number of collaborations in genomics to drive market
- 18.4.4 INDIA
- 18.4.4.1 Government and private initiatives for genomics to propel market
- 18.4.5 AUSTRALIA
- 18.4.5.1 Increased genomics research in Australia to support market growth
- 18.4.6 SOUTH KOREA
- 18.4.6.1 Demand for advanced sequencing technologies to support market growth in South Korea
- 18.4.7 REST OF ASIA PACIFIC
- 18.5 LATIN AMERICA
- 18.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
- 18.5.2 BRAZIL
- 18.5.2.1 Increased government investments in genomics advancements to drive market in Brazil
- 18.5.3 MEXICO
- 18.5.3.1 Rising demand for chronic disease treatment to support market growth in Mexico
- 18.5.4 REST OF LATIN AMERICA
- 18.6 MIDDLE EAST
- 18.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK
- 18.6.2 GCC COUNTRIES
- 18.6.2.1 Saudi Arabia
- 18.6.2.1.1 Growing healthcare expenditure in Saudi Arabia to boost market growth
- 18.6.2.2 United Arab Emirates
- 18.6.2.2.1 Growing collaborations to advance genome sequencing to aid market growth in UAE
- 18.6.2.3 Rest of GCC Countries
- 18.6.2.1 Saudi Arabia
- 18.6.3 REST OF MIDDLE EAST
- 18.7 AFRICA
- 18.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET IN AFRICA
- 18.7.2 AFRICA: MACROECONOMIC OUTLOOK
19 COMPETITIVE LANDSCAPE
- 19.1 INTRODUCTION
- 19.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GENOMICS MARKET
- 19.3 REVENUE ANALYSIS, 2020-2024
- 19.4 MARKET SHARE ANALYSIS, 2024
- 19.5 BRAND/PRODUCT COMPARISON
- 19.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 19.6.1 STARS
- 19.6.2 EMERGING LEADERS
- 19.6.3 PERVASIVE PLAYERS
- 19.6.4 PARTICIPANTS
- 19.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
- 19.6.5.1 Company footprint
- 19.6.5.2 Region footprint
- 19.6.5.3 Product footprint
- 19.6.5.4 Application footprint
- 19.6.5.5 Technology footprint
- 19.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 19.7.1 PROGRESSIVE COMPANIES
- 19.7.2 RESPONSIVE COMPANIES
- 19.7.3 DYNAMIC COMPANIES
- 19.7.4 STARTING BLOCKS
- 19.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
- 19.7.5.1 Detailed list of key startups/SMEs
- 19.7.5.2 Competitive benchmarking of key startups/SMEs
- 19.8 COMPANY VALUATION & FINANCIAL METRICS
- 19.8.1 FINANCIAL METRICS
- 19.8.2 COMPANY VALUATION
- 19.9 COMPETITIVE SCENARIO
- 19.9.1 PRODUCT LAUNCHES
- 19.9.2 DEALS
- 19.9.3 EXPANSIONS
20 COMPANY PROFILES
- 20.1 INTRODUCTION
- 20.2 KEY PLAYERS
- 20.2.1 THERMO FISHER SCIENTIFIC INC.
- 20.2.1.1 Business overview
- 20.2.1.2 Products/Services offered
- 20.2.1.3 Recent developments
- 20.2.1.3.1 Product launches and approvals
- 20.2.1.3.2 Deals
- 20.2.1.3.3 Expansions
- 20.2.1.4 MnM view
- 20.2.1.4.1 Key strengths
- 20.2.1.4.2 Strategic choices
- 20.2.1.4.3 Weaknesses and competitive threats
- 20.2.2 ILLUMINA, INC.
- 20.2.2.1 Business overview
- 20.2.2.2 Products/Services offered
- 20.2.2.3 Recent developments
- 20.2.2.3.1 Product launches and approvals
- 20.2.2.3.2 Deals
- 20.2.2.3.3 Expansions
- 20.2.2.3.4 Other developments
- 20.2.2.4 MnM view
- 20.2.2.4.1 Key strengths
- 20.2.2.4.2 Strategic choices
- 20.2.2.4.3 Weaknesses and competitive threats
- 20.2.3 DANAHER CORPORATION
- 20.2.3.1 Business overview
- 20.2.3.2 Products/Services offered
- 20.2.3.3 Recent developments
- 20.2.3.3.1 Product launches
- 20.2.3.3.2 Deals
- 20.2.3.3.3 Expansions
- 20.2.3.4 MnM view
- 20.2.3.4.1 Key strengths
- 20.2.3.4.2 Strategic choices
- 20.2.3.4.3 Weaknesses and competitive threats
- 20.2.4 F. HOFFMANN-LA ROCHE LTD.
- 20.2.4.1 Business overview
- 20.2.4.2 Products/Services offered
- 20.2.4.2.1 Product launches
- 20.2.4.2.2 Deals
- 20.2.4.2.3 Other developments
- 20.2.4.3 MnM view
- 20.2.4.3.1 Key strengths
- 20.2.4.3.2 Strategic choices
- 20.2.4.3.3 Weaknesses and competitive threats
- 20.2.5 AGILENT TECHNOLOGIES, INC.
- 20.2.5.1 Business overview
- 20.2.5.2 Products/Services offered
- 20.2.5.3 Recent developments
- 20.2.5.3.1 Product launches
- 20.2.5.3.2 Deals
- 20.2.5.3.3 Expansions
- 20.2.5.4 MnM view
- 20.2.5.4.1 Key strengths
- 20.2.5.4.2 Strategic choices
- 20.2.5.4.3 Weaknesses and competitive threats
- 20.2.6 QIAGEN
- 20.2.6.1 Business overview
- 20.2.6.2 Products/Services offered
- 20.2.6.3 Recent developments
- 20.2.6.3.1 Product launches and approvals
- 20.2.6.3.2 Deals
- 20.2.6.3.3 Expansions
- 20.2.7 REVVITY
- 20.2.7.1 Business overview
- 20.2.7.2 Products/Services offered
- 20.2.7.3 Recent developments
- 20.2.7.3.1 Product launches
- 20.2.7.3.2 Deals
- 20.2.7.3.3 Expansions
- 20.2.8 LABORATORY CORPORATION OF AMERICA HOLDINGS
- 20.2.8.1 Business overview
- 20.2.8.2 Services offered
- 20.2.8.3 Recent developments
- 20.2.8.3.1 Service launches
- 20.2.8.3.2 Deals
- 20.2.8.3.3 Expansions
- 20.2.9 IQVIA INC.
- 20.2.9.1 Business overview
- 20.2.9.2 Services offered
- 20.2.9.3 Recent developments
- 20.2.9.3.1 Deals
- 20.2.10 CHARLES RIVER LABORATORIES
- 20.2.10.1 Business overview
- 20.2.10.2 Services offered
- 20.2.11 BIO-RAD LABORATORIES, INC.
- 20.2.11.1 Business overview
- 20.2.11.2 Products/Services offered
- 20.2.11.3 Recent developments
- 20.2.11.3.1 Product launches and approvals
- 20.2.11.3.2 Deals
- 20.2.12 EUROFINS SCIENTIFIC
- 20.2.12.1 Business overview
- 20.2.12.2 Products/Services offered
- 20.2.12.3 Recent developments
- 20.2.12.3.1 Product launches
- 20.2.12.3.2 Deals
- 20.2.13 PACBIO
- 20.2.13.1 Business overview
- 20.2.13.2 Products/Services offered
- 20.2.13.3 Recent developments
- 20.2.13.3.1 Product launches
- 20.2.13.3.2 Deals
- 20.2.13.3.3 Expansions
- 20.2.13.3.4 Other developments
- 20.2.14 OXFORD NANOPORE TECHNOLOGIES PLC.
- 20.2.14.1 Business overview
- 20.2.14.2 Products/Services offered
- 20.2.14.3 Recent developments
- 20.2.14.3.1 Product launches
- 20.2.14.3.2 Deals
- 20.2.14.3.3 Expansions
- 20.2.15 TAKARA BIO INC.
- 20.2.15.1 Business overview
- 20.2.15.2 Products/Services offered
- 20.2.15.3 Recent developments
- 20.2.15.3.1 Product launches
- 20.2.15.3.2 Deals
- 20.2.16 BGI GROUP
- 20.2.16.1 Business overview
- 20.2.16.2 Products/Services offered
- 20.2.16.3 Recent developments
- 20.2.16.3.1 Product & service launches and approvals
- 20.2.16.3.2 Deals
- 20.2.16.3.3 Other developments
- 20.2.17 EPPENDORF SE
- 20.2.17.1 Business overview
- 20.2.17.2 Products/Services offered
- 20.2.17.3 Recent developments
- 20.2.17.3.1 Product launches
- 20.2.18 MERCK KGAA
- 20.2.18.1 Business overview
- 20.2.18.2 Products/Services offered
- 20.2.18.3 Recent developments
- 20.2.18.3.1 Deals
- 20.2.18.3.2 Expansions
- 20.2.19 BD
- 20.2.19.1 Business overview
- 20.2.19.2 Products/Services offered
- 20.2.19.3 Recent developments
- 20.2.19.3.1 Product launches and approvals
- 20.2.19.3.2 Deals
- 20.2.20 ABBOTT
- 20.2.20.1 Business overview
- 20.2.20.2 Products/Services offered
- 20.2.21 10X GENOMICS
- 20.2.21.1 Business overview
- 20.2.21.2 Products/Services offered
- 20.2.21.3 Recent developments
- 20.2.21.3.1 Product launches
- 20.2.22 NEW ENGLAND BIOLABS
- 20.2.22.1 Business overview
- 20.2.22.2 Products/Services offered
- 20.2.22.3 Recent developments
- 20.2.22.3.1 Product launches
- 20.2.22.3.2 Deals
- 20.2.23 PROMEGA CORPORATION
- 20.2.23.1 Business overview
- 20.2.23.2 Products/Services offered
- 20.2.23.3 Recent developments
- 20.2.23.3.1 Product launches
- 20.2.23.3.2 Other developments
- 20.2.1 THERMO FISHER SCIENTIFIC INC.
- 20.3 OTHER PLAYERS
- 20.3.1 CREATIVE BIOGENE
- 20.3.2 NOVOGENE CO., LTD.
- 20.3.3 HELIX, INC.
- 20.3.4 PHALANX BIOTECH GROUP
- 20.3.5 POLARIS GENOMICS
21 APPENDIX
- 21.1 DISCUSSION GUIDE
- 21.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 21.3 CUSTOMIZATION OPTIONS
- 21.4 RELATED REPORTS
- 21.5 AUTHOR DETAILS
List of Tables
- TABLE 1 GENOMICS MARKET: INCLUSIONS & EXCLUSIONS
- TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
- TABLE 3 GENOMICS MARKET: RISK ANALYSIS
- TABLE 4 GENOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
- TABLE 5 GENOMICS MARKET: IMPACT OF PORTER'S FIVE FORCES
- TABLE 6 GENOMICS MARKET: ROLE IN ECOSYSTEM
- TABLE 7 GENOMICS MARKET: EMERGING BUSINESS MODELS & TARGET SEGMENTS
- TABLE 8 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022-2024 (USD)
- TABLE 9 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022-2024 (USD)
- TABLE 10 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 (USD)
- TABLE 11 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022-2024 (USD)
- TABLE 12 IMPORT VALUE FOR HS CODE 3822, 2020-2024 (USD THOUSAND)
- TABLE 13 IMPORT VOLUME FOR HS CODE 3822, 2020-2024 (TONS)
- TABLE 14 IMPORT VALUE FOR HS CODE 902789, 2022-2024 (USD THOUSAND)
- TABLE 15 IMPORT VOLUME FOR HS CODE 902789, 2022-2024 (UNITS)
- TABLE 16 EXPORT VALUE FOR HS CODE 3822, BY COUNTRY, 2019-2023 (USD THOUSAND)
- TABLE 17 EXPORT VOLUME FOR HS CODE 3822, BY COUNTRY, 2019-2023 (TONS)
- TABLE 18 EXPORT VALUE FOR HS CODE 902789, 2022-2024 (USD THOUSAND)
- TABLE 19 EXPORT VOLUME FOR HS CODE 902789, 2022-2024 (UNITS)
- TABLE 20 GENOMICS MARKET: KEY CONFERENCES AND EVENTS, 2026
- TABLE 21 SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER CONTRIBUTING TO IVF FAILURES
- TABLE 22 LONG-READ WHOLE GENOME SEQUENCING WAS USED IN CHILDREN'S MERCY KANSAS CITY
- TABLE 23 US-ADJUSTED RECIPROCAL TARIFF RATES
- TABLE 24 GENOMICS MARKET: INDICATIVE LIST OF PATENTS, 2025
- TABLE 25 CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET
- TABLE 26 CLIENT'S READINESS TO ADOPT GENERATIVE AI IN GENOMICS
- TABLE 27 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 28 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 29 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 30 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 31 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
- TABLE 32 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
- TABLE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
- TABLE 34 KEY BUYING CRITERIA, BY END USER
- TABLE 35 GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 36 GENOMICS PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 37 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 38 EUROPE: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 39 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 40 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 41 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 42 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 43 GENOMICS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 44 NORTH AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 45 EUROPE: GENOMICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 46 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 47 LATIN AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 48 MIDDLE EAST: GENOMICS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 49 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 50 GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 51 GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 52 NORTH AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 53 EUROPE: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 54 ASIA PACIFIC: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 55 LATIN AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 56 MIDDLE EAST: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 57 GCC COUNTRIES: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 58 GENOMICS INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 59 NORTH AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 60 EUROPE: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 61 ASIA PACIFIC: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 62 LATIN AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 63 MIDDLE EAST: GENOMICS INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 64 GCC COUNTRIES: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 65 GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 66 NORTH AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 67 EUROPE: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 68 ASIA PACIFIC: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 69 LATIN AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 70 MIDDLE EAST: GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 71 GCC COUNTRIES: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 72 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 73 SEQUENCING PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 74 NORTH AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 75 EUROPE: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 76 ASIA PACIFIC: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 77 LATIN AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 78 MIDDLE EAST: SEQUENCING PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 79 GCC COUNTRIES: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 80 SEQUENCING PLATFORMS MARKET, BY TYPE, 2023-2030 (UNITS)
- TABLE 81 PCR PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 82 NORTH AMERICA: PCR PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 83 EUROPE: PCR PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 84 ASIA PACIFIC: PCR PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 85 LATIN AMERICA: PCR PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 86 MIDDLE EAST: PCR PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 87 GCC COUNTRIES: PCR PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 88 GENE EDITING PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 89 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 90 EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 91 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 92 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 93 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 94 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 95 FLOW CYTOMETRY PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 96 NORTH AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 97 EUROPE: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 98 ASIA PACIFIC: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 99 LATIN AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 100 MIDDLE EAST: FLOW CYTOMETRY PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 101 GCC COUNTRIES: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 102 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2023-2030 (UNITS)
- TABLE 103 MICROARRAY PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 104 NORTH AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 105 EUROPE: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 106 ASIA PACIFIC: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 107 LATIN AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 108 MIDDLE EAST: MICROARRAY PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 109 GCC COUNTRIES: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 110 IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 111 NORTH AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 112 EUROPE: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 113 ASIA PACIFIC: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 114 LATIN AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 115 MIDDLE EAST: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 116 GCC COUNTRIES: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 117 GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 118 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 119 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 120 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 121 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 122 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 123 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 124 GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 125 GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 126 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 127 EUROPE: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 128 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 129 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 130 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 131 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 132 GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 133 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 134 EUROPE: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 135 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 136 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 137 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 138 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 139 GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 140 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 141 EUROPE: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 142 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 143 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 144 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 145 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 146 GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 147 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 148 EUROPE: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 149 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 150 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 151 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 152 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 153 GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 154 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 155 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 156 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 157 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 158 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 159 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 160 GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 161 GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 162 NORTH AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 163 EUROPE: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 164 ASIA PACIFIC: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 165 LATIN AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 166 MIDDLE EAST: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 167 GCC COUNTRIES: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 168 SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 169 NORTH AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 170 EUROPE: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 171 ASIA PACIFIC: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 172 LATIN AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 173 MIDDLE EAST: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 174 GCC COUNTRIES: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 175 BIOINFORMATICS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 176 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 177 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 178 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 179 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 180 MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 181 GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 182 GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 183 GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 184 NORTH AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 185 EUROPE: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 186 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 187 LATIN AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 188 MIDDLE EAST: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 189 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 190 GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 191 NORTH AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 192 EUROPE: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 193 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 194 LATIN AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 195 MIDDLE EAST: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 196 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 197 GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 198 NORTH AMERICA: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 199 EUROPE: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 200 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 201 LATIN AMERICA: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 202 MIDDLE EAST: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 203 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 204 GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 205 NORTH AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 206 EUROPE: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 207 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 208 LATIN AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 209 MIDDLE EAST: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 210 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 211 GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 212 GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023-2030 (USD MILLION)
- TABLE 213 NORTH AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 214 EUROPE: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 215 ASIA PACIFIC: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 216 LATIN AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 217 MIDDLE EAST: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023-2030 (USD MILLION)
- TABLE 218 GCC COUNTRIES: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 219 GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 220 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 221 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 222 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 223 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 224 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 225 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 226 GENOMICS MARKET FOR DIAGNOSTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 227 GRANTS, BY CANCER TYPE (AS OF OCTOBER 2025)
- TABLE 228 GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 229 NORTH AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 230 EUROPE: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 231 ASIA PACIFIC: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 232 LATIN AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 233 MIDDLE EAST: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 234 GCC COUNTRIES: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 235 GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 236 NORTH AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 237 EUROPE: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 238 ASIA PACIFIC: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 239 LATIN AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 240 MIDDLE EAST: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 241 GCC COUNTRIES: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 242 GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2023-2030 (USD MILLION)
- TABLE 243 NORTH AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 244 EUROPE: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 245 ASIA PACIFIC: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 246 LATIN AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 247 MIDDLE EAST: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2023-2030 (USD MILLION)
- TABLE 248 GCC COUNTRIES: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 249 GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 250 NORTH AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 251 EUROPE: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 252 ASIA PACIFIC: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 253 LATIN AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 254 MIDDLE EAST: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 255 GCC COUNTRIES: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 256 GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2023-2030 (USD MILLION)
- TABLE 257 NORTH AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 258 EUROPE: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 259 ASIA PACIFIC: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 260 LATIN AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 261 MIDDLE EAST: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2023-2030 (USD MILLION)
- TABLE 262 GCC COUNTRIES: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 263 GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 264 NORTH AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 265 EUROPE: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 266 ASIA PACIFIC: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 267 LATIN AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 268 MIDDLE EAST: GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 269 GCC COUNTRIES: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 270 GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 271 GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 272 NORTH AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 273 EUROPE: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 274 ASIA PACIFIC: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 275 LATIN AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 276 MIDDLE EAST: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 277 GCC COUNTRIES: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 278 GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2023-2030 (USD MILLION)
- TABLE 279 NORTH AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 280 EUROPE: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 281 ASIA PACIFIC: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 282 LATIN AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 283 MIDDLE EAST: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2023-2030 (USD MILLION)
- TABLE 284 GCC COUNTRIES: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 285 GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 286 NORTH AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 287 EUROPE: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 288 ASIA PACIFIC: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 289 LATIN AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 290 MIDDLE EAST: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 291 GCC COUNTRIES: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 292 GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 293 NORTH AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 294 EUROPE: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 295 ASIA PACIFIC: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 296 LATIN AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 297 MIDDLE EAST: GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 298 GCC COUNTRIES: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 299 GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 300 NORTH AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 301 EUROPE: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 302 ASIA PACIFIC: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 303 LATIN AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 304 MIDDLE EAST: GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 305 GCC COUNTRIES: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 306 GENOMICS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 307 NORTH AMERICA: KEY MACROINDICATORS
- TABLE 308 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 309 NORTH AMERICA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 310 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 311 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 312 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 313 NORTH AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 314 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 315 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 316 NORTH AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 317 NORTH AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 318 US: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 319 US: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 320 US: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 321 US: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 322 US: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 323 US: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 324 US: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 325 US: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 326 US: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 327 CANADA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 328 CANADA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 329 CANADA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 330 CANADA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 331 CANADA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 332 CANADA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 333 CANADA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 334 CANADA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 335 CANADA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 336 EUROPE: KEY MACROINDICATORS
- TABLE 337 EUROPE: GENOMICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 338 EUROPE: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 339 EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 340 EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 341 EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 342 EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 343 EUROPE: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 344 EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 345 EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 346 EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 347 GERMANY: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 348 GERMANY: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 349 GERMANY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 350 GERMANY: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 351 GERMANY: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 352 GERMANY: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 353 GERMANY: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 354 GERMANY: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 355 GERMANY: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 356 UK: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 357 UK: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 358 UK: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 359 UK: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 360 UK: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 361 UK: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 362 UK: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 363 UK: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 364 UK: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 365 FRANCE: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 366 FRANCE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 367 FRANCE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 368 FRANCE: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 369 FRANCE: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 370 FRANCE: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 371 FRANCE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 372 FRANCE: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 373 FRANCE: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 374 ITALY: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 375 ITALY: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 376 ITALY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 377 ITALY: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 378 ITALY: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 379 ITALY: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 380 ITALY: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 381 ITALY: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 382 ITALY: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 383 SPAIN: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 384 SPAIN: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 385 SPAIN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 386 SPAIN: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 387 SPAIN: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 388 SPAIN: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 389 SPAIN: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 390 SPAIN: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 391 SPAIN: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 392 REST OF EUROPE: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 393 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 394 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 395 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 396 REST OF EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 397 REST OF EUROPE: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 398 REST OF EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 399 REST OF EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 400 REST OF EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 401 ASIA PACIFIC: KEY MACROINDICATORS
- TABLE 402 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 403 ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 404 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 405 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 406 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 407 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 408 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 409 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 410 ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 411 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 412 CHINA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 413 CHINA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 414 CHINA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 415 CHINA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 416 CHINA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 417 CHINA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 418 CHINA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 419 CHINA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 420 CHINA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 421 JAPAN: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 422 JAPAN: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 423 JAPAN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 424 JAPAN: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 425 JAPAN: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 426 JAPAN: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 427 JAPAN: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 428 JAPAN: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 429 JAPAN: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 430 INDIA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 431 INDIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 432 INDIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 433 INDIA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 434 INDIA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 435 INDIA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 436 INDIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 437 INDIA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 438 INDIA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 439 AUSTRALIA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 440 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 441 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 442 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 443 AUSTRALIA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 444 AUSTRALIA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 445 AUSTRALIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 446 AUSTRALIA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 447 AUSTRALIA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 448 SOUTH KOREA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 449 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 450 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 451 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 452 SOUTH KOREA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 453 SOUTH KOREA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 454 SOUTH KOREA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 455 SOUTH KOREA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 456 SOUTH KOREA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 457 REST OF ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 458 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 459 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 460 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 461 REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 462 REST OF ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 463 REST OF ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 464 REST OF ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 465 REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 466 LATIN AMERICA: KEY MACROINDICATORS
- TABLE 467 LATIN AMERICA: GENOMICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 468 LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 469 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 470 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 471 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 472 LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 473 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 474 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 475 LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 476 LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 477 BRAZIL: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 478 BRAZIL: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 479 BRAZIL: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 480 BRAZIL: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 481 BRAZIL: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 482 BRAZIL: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 483 BRAZIL: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 484 BRAZIL: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 485 BRAZIL: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 486 MEXICO: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 487 MEXICO: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 488 MEXICO: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 489 MEXICO: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 490 MEXICO: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 491 MEXICO: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 492 MEXICO: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 493 MEXICO: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 494 MEXICO: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 495 REST OF LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 496 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 497 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 498 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 499 REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 500 REST OF LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 501 REST OF LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 502 REST OF LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 503 REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 504 MIDDLE EAST: KEY MACROINDICATORS
- TABLE 505 MIDDLE EAST: GENOMICS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 506 MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 507 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 508 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 509 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 510 MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 511 MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 512 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 513 MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 514 MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 515 GCC COUNTRIES: GENOMICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 516 GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 517 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 518 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 519 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 520 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 521 GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 522 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 523 GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 524 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 525 SAUDI ARABIA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 526 SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 527 SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 528 SAUDI ARABIA: GENOMICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 529 SAUDI ARABIA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 530 SAUDI ARABIA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 531 SAUDI ARABIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 532 SAUDI ARABIA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 533 SAUDI ARABIA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 534 UNITED ARAB EMIRATES: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 535 UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 536 UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 537 UNITED ARAB EMIRATES: GENOMICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 538 UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 539 UNITED ARAB EMIRATES: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 540 UNITED ARAB EMIRATES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 541 UNITED ARAB EMIRATES: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 542 UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 543 REST OF GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 544 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 545 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 546 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 547 REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 548 REST OF GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 549 REST OF GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 550 REST OF GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 551 REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 552 REST OF MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 553 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 554 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 555 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 556 REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 557 REST OF MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 558 REST OF MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 559 REST OF MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 560 REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 561 AFRICA: KEY MACROINDICATORS
- TABLE 562 AFRICA: GENOMICS MARKET, BY OFFERING, 2023-2030 (USD MILLION)
- TABLE 563 AFRICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 564 AFRICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
- TABLE 565 AFRICA: GENOMICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 566 AFRICA: GENOMICS SERVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 567 AFRICA: GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 568 AFRICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 569 AFRICA: GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
- TABLE 570 AFRICA: GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 571 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN GENOMICS MARKET, JANUARY 2022-OCTOBER 2025
- TABLE 572 GENOMICS PRODUCTS MARKET: DEGREE OF COMPETITION
- TABLE 573 MARKET RANK OF KEY PLAYERS IN GENOMICS SERVICES MARKET (2024)
- TABLE 574 GENOMICS MARKET: REGION FOOTPRINT
- TABLE 575 GENOMICS MARKET: PRODUCT FOOTPRINT
- TABLE 576 GENOMICS MARKET: APPLICATION FOOTPRINT
- TABLE 577 GENOMICS MARKET: TECHNOLOGY FOOTPRINT
- TABLE 578 GENOMICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
- TABLE 579 GENOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS
- TABLE 580 GENOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 581 GENOMICS MARKET: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 582 GENOMICS MARKET: EXPANSIONS, JANUARY 2022-OCTOBER 2025
- TABLE 583 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 584 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
- TABLE 585 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
- TABLE 586 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 587 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022-OCTOBER 2025
- TABLE 588 ILLUMINA, INC.: COMPANY OVERVIEW
- TABLE 589 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
- TABLE 590 ILLUMINA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
- TABLE 591 ILLUMINA, INC.: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 592 ILLUMINA, INC.: EXPANSIONS, JANUARY 2022-OCTOBER 2025
- TABLE 593 ILLUMINA, INC.: OTHER DEVELOPMENTS, JANUARY 2022-OCTOBER 2025
- TABLE 594 DANAHER CORPORATION: COMPANY OVERVIEW
- TABLE 595 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
- TABLE 596 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 597 DANAHER CORPORATION: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 598 DANAHER CORPORATION: EXPANSIONS, JANUARY 2022-OCTOBER 2025
- TABLE 599 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
- TABLE 600 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
- TABLE 601 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 602 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 603 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2022-OCTOBER 2025
- TABLE 604 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 605 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
- TABLE 606 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 607 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 608 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022-OCTOBER 2025
- TABLE 609 QIAGEN: COMPANY OVERVIEW
- TABLE 610 QIAGEN: PRODUCTS/SERVICES OFFERED
- TABLE 611 QIAGEN: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
- TABLE 612 QIAGEN: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 613 QIAGEN: EXPANSIONS, JANUARY 2022-OCTOBER 2025
- TABLE 614 REVVITY: COMPANY OVERVIEW
- TABLE 615 REVVITY: PRODUCTS/SERVICES OFFERED
- TABLE 616 REVVITY: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 617 REVVITY: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 618 REVVITY: EXPANSIONS, JANUARY 2022-OCTOBER 2025
- TABLE 619 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
- TABLE 620 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED
- TABLE 621 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICE LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 622 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 623 LABORATORY CORPORATION OF AMERICA HOLDINGS: EXPANSIONS, JANUARY 2022-OCTOBER 2025
- TABLE 624 IQVIA INC.: COMPANY OVERVIEW
- TABLE 625 IQVIA INC.: SERVICES OFFERED
- TABLE 626 IQVIA INC.: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 627 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
- TABLE 628 CHARLES RIVER LABORATORIES: SERVICES OFFERED
- TABLE 629 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 630 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
- TABLE 631 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
- TABLE 632 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 633 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
- TABLE 634 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
- TABLE 635 EUROFINS SCIENTIFIC: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 636 EUROFINS SCIENTIFIC: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 637 PACBIO: COMPANY OVERVIEW
- TABLE 638 PACBIO: PRODUCTS/SERVICES OFFERED
- TABLE 639 PACBIO: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 640 PACBIO: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 641 PACBIO: EXPANSIONS, JANUARY 2022-OCTOBER 2025
- TABLE 642 PACBIO: OTHER DEVELOPMENTS, JANUARY 2022-OCTOBER 2025
- TABLE 643 OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY OVERVIEW
- TABLE 644 OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCTS/SERVICES OFFERED
- TABLE 645 OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 646 OXFORD NANOPORE TECHNOLOGIES PLC.: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 647 OXFORD NANOPORE TECHNOLOGIES PLC.: EXPANSIONS, JANUARY 2022-OCTOBER 2025
- TABLE 648 TAKARA BIO INC.: COMPANY OVERVIEW
- TABLE 649 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
- TABLE 650 TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 651 TAKARA BIO INC.: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 652 BGI GROUP: COMPANY OVERVIEW
- TABLE 653 BGI GROUP: PRODUCTS/SERVICES OFFERED
- TABLE 654 BGI GROUP: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
- TABLE 655 BGI GROUP: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 656 BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2022-OCTOBER 2025
- TABLE 657 EPPENDORF SE: COMPANY OVERVIEW
- TABLE 658 EPPENDORF SE: PRODUCTS/SERVICES OFFERED
- TABLE 659 EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 660 MERCK KGAA: COMPANY OVERVIEW
- TABLE 661 MERCK KGAA: PRODUCTS/SERVICES OFFERED
- TABLE 662 MERCK KGAA: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 663 MERCK KGAA: EXPANSIONS, JANUARY 2022-OCTOBER 2025
- TABLE 664 BD: COMPANY OVERVIEW
- TABLE 665 BD: PRODUCTS/SERVICES OFFERED
- TABLE 666 BD: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022-OCTOBER 2025
- TABLE 667 BD: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 668 ABBOTT: COMPANY OVERVIEW
- TABLE 669 ABBOTT: PRODUCTS/SERVICES OFFERED
- TABLE 670 10X GENOMICS: COMPANY OVERVIEW
- TABLE 671 10X GENOMICS: PRODUCTS/SERVICES OFFERED
- TABLE 672 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 673 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
- TABLE 674 NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED
- TABLE 675 NEW ENGLAND BIOLABS: PRODUCT LAUNCHES, JANUARY 2021- SEPTEMBER 2024
- TABLE 676 NEW ENGLAND BIOLABS: DEALS, JANUARY 2022-OCTOBER 2025
- TABLE 677 PROMEGA CORPORATION: COMPANY OVERVIEW
- TABLE 678 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
- TABLE 679 PROMEGA CORPORATION: PRODUCT LAUNCHES, JANUARY 2022-OCTOBER 2025
- TABLE 680 PROMEGA CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022-OCTOBER 2025
- TABLE 681 CREATIVE BIOGENE: COMPANY OVERVIEW
- TABLE 682 NOVOGENE CO., LTD.: COMPANY OVERVIEW
- TABLE 683 HELIX, INC.: COMPANY OVERVIEW
- TABLE 684 PHALANX BIOTECH GROUP: COMPANY OVERVIEW
- TABLE 685 POLARIS GENOMICS: COMPANY OVERVIEW
List of Figures
- FIGURE 1 GENOMICS MARKET SEGMENTATION & REGIONAL SCOPE
- FIGURE 2 GENOMICS MARKET: YEARS CONSIDERED
- FIGURE 3 GENOMICS MARKET: RESEARCH DESIGN
- FIGURE 4 GENOMICS MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)
- FIGURE 5 GLOBAL GENOMICS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
- FIGURE 6 GLOBAL GENOMICS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024
- FIGURE 7 GENOMICS MARKET SIZE VALIDATION FROM INDUSTRY EXPERTS
- FIGURE 8 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
- FIGURE 9 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY (COMPANY REVENUE ANALYSIS)
- FIGURE 10 GLOBAL GENOMICS MARKET: CAGR PROJECTIONS (2025-2030)
- FIGURE 11 DATA TRIANGULATION
- FIGURE 12 GENOMICS MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
- FIGURE 13 GENOMICS PRODUCTS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
- FIGURE 14 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
- FIGURE 15 GENOMICS PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
- FIGURE 16 GENOMICS SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
- FIGURE 17 GENOMICS SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
- FIGURE 18 GENOMICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
- FIGURE 19 GENOMICS MARKET, BY STUDY TYPE, 2025 VS. 2030 (USD MILLION)
- FIGURE 20 REGIONAL SNAPSHOT OF GENOMICS MARKET
- FIGURE 21 INCREASING GOVERNMENT FUNDING FOR GENOMICS PROJECTS TO PROPEL MARKET GROWTH
- FIGURE 22 US AND DRUG DISCOVERY & DEVELOPMENT COMMANDED LARGEST MARKET SHARES IN 2024
- FIGURE 23 CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
- FIGURE 24 GENOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 25 BURDEN OF HIV INFECTIONS, BY REGION, 2024
- FIGURE 26 GENOMICS MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 27 GROWTH OF GLOBAL GDP FROM 2020 TO 2024, WITH FORECASTS UNTIL 2030
- FIGURE 28 GENOMICS MARKET: VALUE CHAIN ANALYSIS
- FIGURE 29 GENOMICS MARKET ECOSYSTEM
- FIGURE 30 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022-2024 (USD)
- FIGURE 31 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022-2024 (USD)
- FIGURE 32 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022-2024 (USD)
- FIGURE 33 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN GENOMICS MARKET
- FIGURE 34 PE/VC INVESTMENTS IN LIFE SCIENCES SPLIT BETWEEN PHARMACEUTICALS AND HEALTHCARE
- FIGURE 35 TOP APPLICANTS/OWNERS (COMPANIES) FOR GENOMICS PATENTS, 2014-2024
- FIGURE 36 IMPACT OF AI/GEN AI ON GENOMICS MARKET
- FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
- FIGURE 38 KEY BUYING CRITERIA, BY END USER
- FIGURE 39 NORTH AMERICA: GENOMICS MARKET SNAPSHOT
- FIGURE 40 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT
- FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN GENOMICS MARKET, 2020-2024 (USD BILLION)
- FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GENOMICS PRODUCTS MARKET (2024)
- FIGURE 43 GENOMICS MARKET: BRAND/PRODUCT COMPARISON
- FIGURE 44 GENOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
- FIGURE 45 GENOMICS MARKET: COMPANY FOOTPRINT
- FIGURE 46 GENOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
- FIGURE 47 EV/EBITDA OF KEY VENDORS
- FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
- FIGURE 50 ILLUMINA, INC.: COMPANY SNAPSHOT (2024)
- FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
- FIGURE 52 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024)
- FIGURE 53 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
- FIGURE 54 QIAGEN: COMPANY SNAPSHOT (2024)
- FIGURE 55 REVVITY: COMPANY SNAPSHOT (2024)
- FIGURE 56 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2024)
- FIGURE 57 IQVIA INC.: COMPANY SNAPSHOT (2024)
- FIGURE 58 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
- FIGURE 59 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
- FIGURE 60 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
- FIGURE 61 PACBIO: COMPANY SNAPSHOT (2024)
- FIGURE 62 OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY SNAPSHOT (2024)
- FIGURE 63 TAKARA BIO INC.: COMPANY SNAPSHOT (2024)
- FIGURE 64 EPPENDORF SE: COMPANY SNAPSHOT (2024)
- FIGURE 65 MERCK KGAA: COMPANY SNAPSHOT (2024)
- FIGURE 66 BD: COMPANY SNAPSHOT (2024)
- FIGURE 67 ABBOTT: COMPANY SNAPSHOT (2024)
- FIGURE 68 10X GENOMICS: COMPANY SNAPSHOT (2024)
02-2729-4219
+886-2-2729-4219
功能基因体学市场－全球产业规模、份额、趋势、机会和预测，依产品、技术、应用、最终用户、地区和竞争格局划分，2020-2030年预测
农业基因组学市场规模、份额和成长分析（按技术、产品类型、应用、最终用户和地区划分）—2025-2032年产业预测
全球基因组学市场预测（至2032年）：依产品、功能、交付模式、技术、应用、最终用户和地区进行分析资料无尘室市场预测至2032年：按组件、部署类型、组织规模、技术、应用、最终用户和地区分類的全球分析
基因组学市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）全球资料无尘室平台市场：预测至 2032 年－按组件、部署方式、组织规模、应用、最终用户和地区进行分析
功能基因体学市场按产品类型、技术、应用和最终用户划分－2025-2032年全球预测基因组学市场（按产品类型、应用、最终用户和技术）—2025-2032 年全球预测消费者基因体学市场按产品类型、技术、测试类型、应用和最终用户划分－2025-2032年全球预测
光学基因组图谱市场规模、份额、按产品、方法、最终用途、组件和地区分類的成长分析 - 产业预测，2025 年至 2032 年
▼